Cystatin-C and inflammatory markers in the ambulatory elderly

American Journal of Medicine

Volumn 118, Issue 12, 2005, Pages 1416.e25-1416.e31

  Shlipak, Michael G ^a,i   Katz, Ronit ^b   Cushman, Mary ^c   Sarnak, Mark J ^d   Stehman Breen, Catherine ^e   Psaty, Bruce M ^f   Siscovick, David ^f   Tracy, Russell P ^c   Newman, Anne ^g,h   Fried, Linda ⁱ  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Departments of Neurology and Epidemiology   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e AMGEN INC   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

C reactive protein; Creatinine; Cystatin C; Fibrinogen; Inflammation; Kidney disease

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; CYSTATIN C; FIBRINOGEN;

AGED; AGING; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE MARKER; FEMALE; FIBRINOGEN BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; KIDNEY FAILURE; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 29244474588     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.07.060     Document Type: Article

References (26)

1. M.G. Shlipak, L.F. Fried, C. Crump Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency Circulation. 107 1 2003 87 92
2. P. Muntner, L.L. Hamm, J.W. Kusek The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease Ann Intern Med. 140 1 2004 9 17
3. A.D. Rule, T.S. Larson, E.J. Bergstralh Using serum creatinine to estimate glomerular filtration rate accuracy in good health and in chronic kidney disease Ann Intern Med. 141 12 2004 929 937
4. V.R. Dharnidharka, C. Kwon, G. Stevens Serum cystatin C is superior to serum creatinine as a marker of kidney function a meta-analysis Am J Kidney Dis. 40 2 2002 221 226
5. R. Hojs, S. Bevc, B. Antolinc Serum cystatin C as an endogenous marker of renal function in the elderly Int J Clin Pharmacol Res. 24 2-3 2004 49 54
6. A. Grubb, U. Nyman, J. Bjork Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children Clin Chem. 51 8 2005 1420 1431
7. T. Jernberg, B. Lindahl, S. James Cystatin C. A novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome Circulation. 110; 2004 2342 2348
8. M.G. Shlipak, M.J. Sarnak, R. Katz Cystatin C and the risk of death and cardiovascular events among elderly persons N Engl J Med. 352 20 2005 2049 2060
9. M.J. Sarnak, R. Katz, C.O. Stehman-Breen Cystatin C concentration as a risk factor for heart failure in older adults Ann Intern Med. 142 7 2005 497 505
10. L.P. Fried, N.O. Borhani, P. Enright The Cardiovascular Health Study design and rationale Ann Epidemiol. 1 1991 263 276
11. G.S. Tell, L.P. Fried, B. Hermanson Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study Ann Epidemiol. 3 4 1993 358 366
12. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease evaluation, classification, and stratification Am J Kidney Dis. 39 Suppl 2 2002 S1 S266
13. E.J. Erlandsen, E. Randers, J.H. Kristensen Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System Scand J Clin Lab Invest. 59 1 1999 1 8
14. E.M. Macy, T.E. Hayes, R.P. Tracy Variability in the measurement of C-reactive protein in healthy subjects implications for reference intervals and epidemiological applications Clin Chem. 43 1 1997 52 58
15. R.P. Tracy, A.M. Arnold, W. Ettinger The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly results from the Cardiovascular Health Study Arterioscler Thromb Vasc Biol. 19 7 1999 1776 1783
16. M. Cushman, E.S. Cornell, P.R. Howard Laboratory methods and quality assurance in the Cardiovascular Health Study Clin Chem. 41 2 1995 264 270
17. N.D. Vaziri, E.C. Gonzales, J. Wang, S. Said Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease effect of hemodialysis Am J Kidney Dis. 23 6 1994 828 835
18. R.M. Bologa, D.M. Levine, T.S. Parker Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients Am J Kidney Dis. 32 1 1998 107 114
19. W.F. Owen, E.G. Lowrie C-reactive protein as an outcome predictor for maintenance hemodialysis patients Kidney Int. 54 2 1998 627 636
20. P. Stenvinkel, O. Heimburger, F. Paultre Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure Kidney Int. 55 5 1999 1899 1911
21. B.A. Perkins, R.G. Nelson, B.E. Ostrander Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration results of a 4-year follow-up study J Am Soc Nephrol. 16 5 2005 1404 1412
22. G. Curhan Cystatin C a marker of renal function or something more? Clin Chem. 51 2 2005 293 294
23. W. Koenig, D. Twardella, H. Brenner, D. Rothenbacher Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events more than simply a marker of glomerular filtration rate Clin Chem. 51 2 2005 321 327
24. E.L. Knight, J.C. Verhave, D. Spiegelman Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement Kidney Int. 65 4 2004 1416 1421
25. A.S. Levey, J.P. Bosch, J.B. Lewis Modification of Diet in Renal Disease Study Group A more accurate method to estimate glomerular filtration rate from serum creatinine a new prediction equation Ann Intern Med. 130 6 1999 461 470
26. H. Finney, D.J. Newman, W. Gruber Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II) Clin Chem. 43 6 Pt 1 1997 1016 1022